Publication | Closed Access

Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells

Gastrointestinal Peptide HormoneNeurophysiologyMedicinePhysiologyMast CellsNerve Growth FactorHypothalamic PeptideNeuropharmacologyNeuropeptide ReceptorVasoactive Intestinal PeptideNeuroscienceNervous SystemPharmacologyNeuroimmunologySocial SciencesNeuropeptides